IBDEI0LG ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,176,0)
 ;;=MEDICATIONS^5^15
 ;;^UTILITY(U,$J,358.4,177,0)
 ;;=NEW PATIENT^2^16
 ;;^UTILITY(U,$J,358.4,178,0)
 ;;=ESTABLISHED PATIENT^1^16
 ;;^UTILITY(U,$J,358.4,179,0)
 ;;=CONSULTATIONS^3^16
 ;;^UTILITY(U,$J,358.4,180,0)
 ;;=MYOCARDIAL INFARCTION^11^17
 ;;^UTILITY(U,$J,358.4,181,0)
 ;;=CHF / MYOPATHY / TRANSPLANT^3^17
 ;;^UTILITY(U,$J,358.4,182,0)
 ;;=ARRHYTHMIA^1^17
 ;;^UTILITY(U,$J,358.4,183,0)
 ;;=PERIPHERAL VASC DIS^16^17
 ;;^UTILITY(U,$J,358.4,184,0)
 ;;=INFECT/INFLAM DISEASE^9^17
 ;;^UTILITY(U,$J,358.4,185,0)
 ;;=SYNCOPE/HYPOTENSION^19^17
 ;;^UTILITY(U,$J,358.4,186,0)
 ;;=GENERAL SYMPTOMS^6^17
 ;;^UTILITY(U,$J,358.4,187,0)
 ;;=LIPID DISORDERS^10^17
 ;;^UTILITY(U,$J,358.4,188,0)
 ;;=SCREENING^18^17
 ;;^UTILITY(U,$J,358.4,189,0)
 ;;=CHEST PAIN^2^17
 ;;^UTILITY(U,$J,358.4,190,0)
 ;;=CORONARY ATHEROSCLEROSIS^5^17
 ;;^UTILITY(U,$J,358.4,191,0)
 ;;=OTHER FORMS OF HEART DISEASE^14^17
 ;;^UTILITY(U,$J,358.4,192,0)
 ;;=HYPERTENSION^8^17
 ;;^UTILITY(U,$J,358.4,193,0)
 ;;=NONRHEUMATIC HEART VALVE DISEASE^12^17
 ;;^UTILITY(U,$J,358.4,194,0)
 ;;=RHEUMATIC HEART DISEASE^17^17
 ;;^UTILITY(U,$J,358.4,195,0)
 ;;=COMPLICATIONS^4^17
 ;;^UTILITY(U,$J,358.4,196,0)
 ;;=HISTORY CODES^7^17
 ;;^UTILITY(U,$J,358.4,197,0)
 ;;=OTHER CONDITIONS^13^17
 ;;^UTILITY(U,$J,358.4,198,0)
 ;;=SCREENING FOR MENTAL/DEVELOPMENT^6^18
 ;;^UTILITY(U,$J,358.4,199,0)
 ;;=PERSONS SEEKING CONSULT^5^18
 ;;^UTILITY(U,$J,358.4,200,0)
 ;;=FAMILY CIRCUMSTANCES^2^18
 ;;^UTILITY(U,$J,358.4,201,0)
 ;;=MENTAL AND BEHAVIORAL PROBLEMS^4^18
 ;;^UTILITY(U,$J,358.4,202,0)
 ;;=ADMINISTRATIVE PURPOSES^1^18
 ;;^UTILITY(U,$J,358.4,203,0)
 ;;=HOUSING & ECONOMIC CIRCUMSTANCES^3^18
 ;;^UTILITY(U,$J,358.4,204,0)
 ;;=TEAM CONFERENCE^3^19
 ;;^UTILITY(U,$J,358.4,205,0)
 ;;=SOCIAL WORKER^2^19
 ;;^UTILITY(U,$J,358.4,206,0)
 ;;=PSYCH^1^19
 ;;^UTILITY(U,$J,358.4,207,0)
 ;;=CLINICIAN^1^20
 ;;^UTILITY(U,$J,358.4,208,0)
 ;;=SUBSEQUENT NRSG FACILITY CARE^2^21
 ;;^UTILITY(U,$J,358.4,209,0)
 ;;=INITIAL NRSG FACILITY CARE^1^21
 ;;^UTILITY(U,$J,358.4,210,0)
 ;;=INPT-CONSULTATIONS^3^21
 ;;^UTILITY(U,$J,358.4,211,0)
 ;;=DISCHARGE DAY VISIT^5^21
 ;;^UTILITY(U,$J,358.4,212,0)
 ;;=OTH NURSG FACILITY SVCS^4^21
 ;;^UTILITY(U,$J,358.4,213,0)
 ;;=INPT VENT MGMT^1^22
 ;;^UTILITY(U,$J,358.4,214,0)
 ;;=CARDIOVASCULAR^3^23
 ;;^UTILITY(U,$J,358.4,215,0)
 ;;=RESPIRATORY^15^23
 ;;^UTILITY(U,$J,358.4,216,0)
 ;;=MUSCULOSKELETAL^11^23
 ;;^UTILITY(U,$J,358.4,217,0)
 ;;=NEURO^12^23
 ;;^UTILITY(U,$J,358.4,218,0)
 ;;=GASTROENTEROLOGY^5^23
 ;;^UTILITY(U,$J,358.4,219,0)
 ;;=GENITOURINARY^6^23
 ;;^UTILITY(U,$J,358.4,220,0)
 ;;=HEMATOLOGY/ONCOLOGY^7^23
 ;;^UTILITY(U,$J,358.4,221,0)
 ;;=INJURY/TRAUMA^8^23
 ;;^UTILITY(U,$J,358.4,222,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^17^23
 ;;^UTILITY(U,$J,358.4,223,0)
 ;;=PAIN^13^23
 ;;^UTILITY(U,$J,358.4,224,0)
 ;;=COMPLICATIONS^4^23
 ;;^UTILITY(U,$J,358.4,225,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^1^23
 ;;^UTILITY(U,$J,358.4,226,0)
 ;;=V CODES^18^23
 ;;^UTILITY(U,$J,358.4,227,0)
 ;;=MASS^9^23
 ;;^UTILITY(U,$J,358.4,228,0)
 ;;=SCI^16^23
 ;;^UTILITY(U,$J,358.4,229,0)
 ;;=ALZHEIMERS^2^23
 ;;^UTILITY(U,$J,358.4,230,0)
 ;;=MEDICAL^10^23
 ;;^UTILITY(U,$J,358.4,231,0)
 ;;=PSYCHIATRIC^14^23
 ;;^UTILITY(U,$J,358.4,232,0)
 ;;=OTHER^3^24
 ;;^UTILITY(U,$J,358.4,233,0)
 ;;=COMMONLY USED CODES^1^24
 ;;^UTILITY(U,$J,358.4,234,0)
 ;;=WARFARIN CLINIC CODES^2^24
 ;;^UTILITY(U,$J,358.4,235,0)
 ;;=PRIMARY DIAGNOSIS^1^25
 ;;^UTILITY(U,$J,358.4,236,0)
 ;;=NEW PATIENT^1^26
 ;;^UTILITY(U,$J,358.4,237,0)
 ;;=ESTABLISHED PATIENT^2^26
 ;;^UTILITY(U,$J,358.4,238,0)
 ;;=EDUCATION & TRAINING FOR SELF MGMT^3^26
 ;;^UTILITY(U,$J,358.4,239,0)
 ;;=INPATIENT ADMISSION VISIT^2^27
 ;;^UTILITY(U,$J,358.4,240,0)
 ;;=INPATIENT CONSULTS^1^27
 ;;^UTILITY(U,$J,358.4,241,0)
 ;;=INPATIENT SUBSEQUENT VISIT^3^27
 ;;^UTILITY(U,$J,358.4,242,0)
 ;;=DISCHARGE VISIT^4^27
 ;;^UTILITY(U,$J,358.4,243,0)
 ;;=OBSERVATION ADMISSION^5^27
 ;;^UTILITY(U,$J,358.4,244,0)
 ;;=OBSERVATION DISCHARGE^7^27
 ;;^UTILITY(U,$J,358.4,245,0)
 ;;=OBSERVATION SUBSEQUENT VISIT^6^27
 ;;^UTILITY(U,$J,358.4,246,0)
 ;;=CARDIAC^2^28
 ;;^UTILITY(U,$J,358.4,247,0)
 ;;=ENDOCRINE/METABOLIC^5^28
 ;;^UTILITY(U,$J,358.4,248,0)
 ;;=PULMONARY^20^28
 ;;^UTILITY(U,$J,358.4,249,0)
 ;;=EENT^4^28
 ;;^UTILITY(U,$J,358.4,250,0)
 ;;=MUSCULOSKELETAL^13^28
 ;;^UTILITY(U,$J,358.4,251,0)
 ;;=NEUROLOGIC^14^28
 ;;^UTILITY(U,$J,358.4,252,0)
 ;;=MENTAL HEALTH^12^28
 ;;^UTILITY(U,$J,358.4,253,0)
 ;;=GASTROENTEROLOGY^6^28
 ;;^UTILITY(U,$J,358.4,254,0)
 ;;=GU / RENAL^7^28
 ;;^UTILITY(U,$J,358.4,255,0)
 ;;=CANCER^3^28
 ;;^UTILITY(U,$J,358.4,256,0)
 ;;=HEMATOLOGIC & LYMPHATIC^8^28
 ;;^UTILITY(U,$J,358.4,257,0)
 ;;=INFECTIOUS DISEASE^10^28
 ;;^UTILITY(U,$J,358.4,258,0)
 ;;=SKIN^24^28
 ;;^UTILITY(U,$J,358.4,259,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^22^28
 ;;^UTILITY(U,$J,358.4,260,0)
 ;;=INTERSTITIAL LUNG DISEASE^11^28
 ;;^UTILITY(U,$J,358.4,261,0)
 ;;=PAIN^18^28
 ;;^UTILITY(U,$J,358.4,262,0)
 ;;=OTHER^17^28
 ;;^UTILITY(U,$J,358.4,263,0)
 ;;=COMMON PULMONARY DIAGNOSES^1^28
 ;;^UTILITY(U,$J,358.4,264,0)
 ;;=NEUROMUSCULAR/SKELETAL^15^28
 ;;^UTILITY(U,$J,358.4,265,0)
 ;;=OCCUPATIONAL^16^28
 ;;^UTILITY(U,$J,358.4,266,0)
 ;;=PLEURAL DISEASE^19^28
 ;;^UTILITY(U,$J,358.4,267,0)
 ;;=RADIATION^21^28
 ;;^UTILITY(U,$J,358.4,268,0)
 ;;=SKELETAL^23^28
 ;;^UTILITY(U,$J,358.4,269,0)
 ;;=HEPATIC & BILIARY^9^28
 ;;^UTILITY(U,$J,358.4,270,0)
 ;;=SUTURES/DRESSINGS^25^28
 ;;^UTILITY(U,$J,358.4,271,0)
 ;;=VASCULAR^26^28
 ;;^UTILITY(U,$J,358.4,272,0)
 ;;=BEDSIDE PROCEDURES^1^29
 ;;^UTILITY(U,$J,358.4,273,0)
 ;;=BLOODS,ARTERIAL & VENOUS^2^29
 ;;^UTILITY(U,$J,358.4,274,0)
 ;;=BRONCHOSCOPY^3^29
 ;;^UTILITY(U,$J,358.4,275,0)
 ;;=EXERCISE TESTING^4^29
 ;;^UTILITY(U,$J,358.4,276,0)
 ;;=OXIMETRY^6^29
 ;;^UTILITY(U,$J,358.4,277,0)
 ;;=PULMONARY FUCTION TESTING^7^29
 ;;^UTILITY(U,$J,358.4,278,0)
 ;;=RESPIRATORY THERAPY^8^29
 ;;^UTILITY(U,$J,358.4,279,0)
 ;;=THORACENTESIS^10^29
 ;;^UTILITY(U,$J,358.4,280,0)
 ;;=INTENSIVE CARE^5^29
 ;;^UTILITY(U,$J,358.4,281,0)
 ;;=TELE-HEALTH ICU^9^29
 ;;^UTILITY(U,$J,358.4,282,0)
 ;;=NEW PATIENT^2^30
 ;;^UTILITY(U,$J,358.4,283,0)
 ;;=ESTABLISHED PATIENT^1^30
 ;;^UTILITY(U,$J,358.4,284,0)
 ;;=CONSULTATIONS^3^30
 ;;^UTILITY(U,$J,358.4,285,0)
 ;;=POST-OP FOLLOW-UP^4^30
 ;;^UTILITY(U,$J,358.4,286,0)
 ;;=ABRASION w/o INFECTION^1^31
 ;;^UTILITY(U,$J,358.4,287,0)
 ;;=ABRASION w/ INFECTION^2^31
 ;;^UTILITY(U,$J,358.4,288,0)
 ;;=ABSCESS/CELLULITIS^3^31
 ;;^UTILITY(U,$J,358.4,289,0)
 ;;=ACNE^4^31
 ;;^UTILITY(U,$J,358.4,290,0)
 ;;=ALOPEICA^5^31
 ;;^UTILITY(U,$J,358.4,291,0)
 ;;=BURNS^6^31
 ;;^UTILITY(U,$J,358.4,292,0)
 ;;=CANDIDIASIS^7^31
 ;;^UTILITY(U,$J,358.4,293,0)
 ;;=CELLULITIS^8^31
 ;;^UTILITY(U,$J,358.4,294,0)
 ;;=DERMATITIS^9^31
 ;;^UTILITY(U,$J,358.4,295,0)
 ;;=DERMATOPHYTOSIS^10^31
 ;;^UTILITY(U,$J,358.4,296,0)
 ;;=ECZEMA^11^31
 ;;^UTILITY(U,$J,358.4,297,0)
 ;;=EDEMA^12^31
 ;;^UTILITY(U,$J,358.4,298,0)
 ;;=ERYTHEMA^13^31
 ;;^UTILITY(U,$J,358.4,299,0)
 ;;=EXPOSURE TO HEALTH HAZARDS^14^31
 ;;^UTILITY(U,$J,358.4,300,0)
 ;;=FOLLICULITIS^15^31
 ;;^UTILITY(U,$J,358.4,301,0)
 ;;=FURUNCLE^16^31
 ;;^UTILITY(U,$J,358.4,302,0)
 ;;=GRANULOMA^17^31
 ;;^UTILITY(U,$J,358.4,303,0)
 ;;=HERPES^35^31
 ;;^UTILITY(U,$J,358.4,304,0)
 ;;=HISTORY^36^31
 ;;^UTILITY(U,$J,358.4,305,0)
 ;;=ICHTHYOSIS^38^31
 ;;^UTILITY(U,$J,358.4,306,0)
 ;;=INSECT BITE w/o INFECTION^39^31
 ;;^UTILITY(U,$J,358.4,307,0)
 ;;=INSECT BITE w/INFECTION^40^31
 ;;^UTILITY(U,$J,358.4,308,0)
 ;;=KERATOSIS^42^31
 ;;^UTILITY(U,$J,358.4,309,0)
 ;;=LACERATION^44^31
 ;;^UTILITY(U,$J,358.4,310,0)
 ;;=LESION^46^31
 ;;^UTILITY(U,$J,358.4,311,0)
 ;;=LICHENIFICATION^47^31
 ;;^UTILITY(U,$J,358.4,312,0)
 ;;=LUPUS^48^31
 ;;^UTILITY(U,$J,358.4,313,0)
 ;;=MELANOMA^50^31
 ;;^UTILITY(U,$J,358.4,314,0)
 ;;=NAIL DISEASE^53^31
 ;;^UTILITY(U,$J,358.4,315,0)
 ;;=NEOPLASM-BENIGN^54^31
 ;;^UTILITY(U,$J,358.4,316,0)
 ;;=NEOPLASM-IN SITU^56^31
 ;;^UTILITY(U,$J,358.4,317,0)
 ;;=NEOPLASM-OTHER^57^31
 ;;^UTILITY(U,$J,358.4,318,0)
 ;;=NEURODERMATITIS^58^31
 ;;^UTILITY(U,$J,358.4,319,0)
 ;;=PEDICULOSIS^61^31
 ;;^UTILITY(U,$J,358.4,320,0)
 ;;=PITYRIASIS^62^31
 ;;^UTILITY(U,$J,358.4,321,0)
 ;;=PRURITUS^63^31
 ;;^UTILITY(U,$J,358.4,322,0)
 ;;=PSORIASIS^64^31
 ;;^UTILITY(U,$J,358.4,323,0)
 ;;=STASIS^66^31
 ;;^UTILITY(U,$J,358.4,324,0)
 ;;=ULCER^68^31
 ;;^UTILITY(U,$J,358.4,325,0)
 ;;=ULCER-LOWER EXTREMITY^69^31
 ;;^UTILITY(U,$J,358.4,326,0)
 ;;=URTICARIA^70^31
 ;;^UTILITY(U,$J,358.4,327,0)
 ;;=VARICOSE VEINS^71^31
 ;;^UTILITY(U,$J,358.4,328,0)
 ;;=WOUND^73^31
 ;;^UTILITY(U,$J,358.4,329,0)
 ;;="A" MISC DIAGNOSIS^5.1^31
 ;;^UTILITY(U,$J,358.4,330,0)
 ;;="B" MISC DIAGNOSIS^6.1^31
 ;;^UTILITY(U,$J,358.4,331,0)
 ;;="C" MISC DIAGNOSIS^8.1^31
 ;;^UTILITY(U,$J,358.4,332,0)
 ;;="D" MISC DIAGNOSIS^10.1^31
 ;;^UTILITY(U,$J,358.4,333,0)
 ;;="E" MISC DIAGNOSIS^14.1^31
 ;;^UTILITY(U,$J,358.4,334,0)
 ;;="F" MISC DIAGNOSIS^16.1^31
 ;;^UTILITY(U,$J,358.4,335,0)
 ;;="H" MISC DIAGNOSIS^37^31
 ;;^UTILITY(U,$J,358.4,336,0)
 ;;="I" MISC DIAGNOSIS^41^31
 ;;^UTILITY(U,$J,358.4,337,0)
 ;;="K" MISC DIAGNOSIS^43^31
 ;;^UTILITY(U,$J,358.4,338,0)
 ;;="L" MISC DIAGNOSIS^49^31
 ;;^UTILITY(U,$J,358.4,339,0)
 ;;="M" MISC DIAGNOSIS^51^31
 ;;^UTILITY(U,$J,358.4,340,0)
 ;;="N" MISC DIAGNOSIS^59^31
 ;;^UTILITY(U,$J,358.4,341,0)
 ;;="P" MISC DIAGNOSIS^65^31
 ;;^UTILITY(U,$J,358.4,342,0)
 ;;="X" MISC DIAGNOSIS^75^31
 ;;^UTILITY(U,$J,358.4,343,0)
 ;;="V" MISC DIAGNOSIS^72^31
 ;;^UTILITY(U,$J,358.4,344,0)
 ;;="W" MISC DIAGNOSIS^74^31
 ;;^UTILITY(U,$J,358.4,345,0)
 ;;=AFTERCARE CODES^0^31
 ;;^UTILITY(U,$J,358.4,346,0)
 ;;="S" MISC DIAGNOSIS^67^31
 ;;^UTILITY(U,$J,358.4,347,0)
 ;;=CANCER (NOT MELANOMA)^6.5^31
 ;;^UTILITY(U,$J,358.4,348,0)
 ;;=BOIL/FURUNCLE^5.5^31
 ;;^UTILITY(U,$J,358.4,349,0)
 ;;=CHEILITIS^8.03^31
 ;;^UTILITY(U,$J,358.4,350,0)
 ;;=CYST^8.07^31
 ;;^UTILITY(U,$J,358.4,351,0)
 ;;=DRUG REACTION^10.02^31
